Illicit and prescription drug use and psychotic experiences among university students in the United States

References

• Abdullah, M. F. I. L. B., Singh, D., Swogger, M. T., Rahim, A. A., & Vicknasingam, B. (2019). The prevalence of psychotic symptoms in kratom (Mitragyna speciosa Korth.) Users in Malaysia. Asian Journal of Psychiatry, 43, 197–201. https://doi.org/10.1016/j.ajp.2019.07.008
   PubMed Web of Science ®Google Scholar
• Ashok, A. H., Mizuno, Y., Volkow, N. D., & Howes, O. D. (2017). Associations of stimulant use with dopaminergic alterations in users of cocaine, amphetamine or methamphetamine: A systematic review and meta-analysis. JAMA Psychiatry, 74(5), 511–519. https://doi.org/10.1001/jamapsychiatry.2017.0135
   PubMed Web of Science ®Google Scholar
• Bagot, K. S., & Chang, A. (2018). Marijuana and psychosis: Policy implications for treatment providers. Journal of the American Academy of Child and Adolescent Psychiatry, 57(8), 613–614. https://doi.org/10.1016/j.jaac.2018.05.010
   PubMed Web of Science ®Google Scholar
• Baker, R., Brick, J. M., Bates, N. A., Battaglia, M., Couper, M. P., Dever, J. A., Gile, K. J., & Tourangeau, R. (2013). Summary report of the AAPOR task force on non-probability sampling. Journal of Survey Statistics and Methodology, 1(2), 90–143. https://doi.org/10.1093/jssam/smt008
   Google Scholar
• Barkus, E., & Murray, R. M. (2009). Substance use in severe mental illness: Self-medication and vulnerability factors. Psychiatry Research, 165(1–2), 88–95. https://doi.org/10.1016/j.psychres.2007.10.009
   PubMed Web of Science ®Google Scholar
• Barkus, E., & Murray, R. M. (2010). Substance use in adolescence and psychosis: Clarifying the relationship. Annual Review of Clinical Psychology, 6(1), 365–389. https://doi.org/10.1146/annurev.clinpsy.121208.131220
   PubMed Web of Science ®Google Scholar
• Bizzarri, J. V. (2009). Substance use in severe mental illness: Self-medication and vulnerability factors. Psychiatry Research, 165(1–2), 88–95. https://doi.org/10.1016/j.psychres.2007.10.009
   PubMed Web of Science ®Google Scholar
• Burns, J. K. (2013). Pathways from cannabis to psychosis: A review of the evidence. Frontiers in Psychiatry, 4, 128. https://doi.org/10.3389/fpsyt.2013.00128
   PubMedGoogle Scholar
• Carol, E. E., Spencer, R. L., & Mittal, V. A. (2017). The relationship between cannabis use and cortisol levels in youth at ultra high-risk for psychosis. Psychoneuroendocrinology, 83, 58–64. https://doi.org/10.1016/j.psyneuen.2017.04.017
   PubMed Web of Science ®Google Scholar
• Clark, S. L., Chan, R., Zhao, M., Xie, L. Y., Copeland, W. E., Aberg, K. A., & van den Oord, E. J. C. G. (2021). Methylomic investigation of problematic adolescent cannabis use and its negative mental health consequences. Journal of the American Academy of Child and Adolescent Psychiatry, 60(12), 1524–1532. https://doi.org/10.1016/j.jaac.2021.02.008
   PubMed Web of Science ®Google Scholar
• Cohen, C. I., & Marino, L. (2013). Racial and ethnic differences in the prevalence of psychotic symptoms in the general population. Psychiatric Services, 64(11), 1103–1109. https://doi.org/10.1176/appi.ps.201200348
   PubMed Web of Science ®Google Scholar
• Craig, B. M., Hays, R. D., Pickard, A. S., Cella, D., Revicki, D. A., & Reeve, B. B. (2013). Comparison of US panel vendors for online surveys. Journal of Medical Internet Research, 15(11), e260. https://doi.org/10.2196/jmir.2903
   PubMed Web of Science ®Google Scholar
• Danjiu, Y., Bossong, M. G., Brandt, K., & Allen, P. (2018). The associations between psychotic experiences and substance use disorders: Findings from the World Health Organization World Mental Health Surveys. Addiction, 113(5), 924–934. https://doi.org/10.1111/add.14145
   PubMed Web of Science ®Google Scholar
• Danjiu, Y., Bossong, M. G., Brandt, K., & Allen, P. (2020). Do the effects of cannabis on the hippocampus and striatum increase risk for psychosis? Neuroscience and Biobehavioral Reviews, 112, 324–335. https://doi.org/10.1016/j.neubiorev.2020.02.010
   PubMed Web of Science ®Google Scholar
• Degenhardt L. Saha, S., Lim, C. C., Aguilar‐Gaxiola, S., Al‐Hamzawi, A., Alonso, J., ... & WHO World Mental Health Survey Collaborators. (2018). The associations between psychotic experiences and substance use and substance use disorders: Findings from the World Health Organization World Mental Health surveys. Addiction, 113(5), 924–934. https://doi.org/10.1111/add.14145
   PubMed Web of Science ®Google Scholar
• DeVylder, J. E., Burnette, D., & Yang, L. H. (2014). Co-occurrence of psychotic experiences and common mental health conditions across four racially and ethnically diverse population samples. Psychological Medicine, 44(16), 3503. https://doi.org/10.1017/S0033291714000944
   PubMed Web of Science ®Google Scholar
• Glasner-Edwards, S., & Mooney, L. J. (2014). Methamphetamine psychosis: Epidemiology and management. CNS Drugs, 28(12), 1115–1126. https://doi.org/10.1007/s40263-014-0209-8
   PubMed Web of Science ®Google Scholar
• Gregg, L., Barrowclough, C., & Haddock, G. (2007). Reasons for increased substance use in psychosis. Clinical Psychology Review, 27(4), 494–510. https://doi.org/10.1016/j.cpr.2006.09.004
   PubMed Web of Science ®Google Scholar
• Gurillo, P., Jauhar, S., Murray, R. M., & MacCabe, J. H. (2015). Does tobacco use cause psychosis? Systematic review and meta-analysis. The Lancet Psychiatry, 2(8), 718–725. https://doi.org/10.1016/S2215-0366(15)00152-2.
   PubMed Web of Science ®Google Scholar
• Kendler, K. S., Gallagher, T. J., Abelson, J. M., & Kessler, R. C. (1996). Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample: The National Comorbidity Survey. Arch Gen Psychiatry, 53(11), 1022-1031. https://doi.org/10.1001/archpsyc.1996.01830110060007
   PubMed Web of Science ®Google Scholar
• Khantzian, E. J. (1997). The self-medication hypothesis of substance use disorders: A reconsideration and recent applications. Harvard Review of Psychiatry, 4(5), 231–244. https://doi.org/10.3109/10673229709030550
   PubMed Web of Science ®Google Scholar
• Khokar, J. Y., Dwiel, L. L., Henricks, A. M., Doucette, W. T., & Green, A. I. (2018). The link between schizophrenia and substance use disorder: A unifying hypothesis. Schizophrenia Research, 194, 78–85. https://doi.org/10.1016/j.schres.2017.04.016
   PubMed Web of Science ®Google Scholar
• Koyanagi, A., Stickley, A., & Haro, J. M. (2016). Psychotic symptoms and smoking in 44 countries. Acta Psychiatrica Scandinavica, 133(6), 497–505. https://doi.org/10.1111/acps.12566
   PubMed Web of Science ®Google Scholar
• Krebs, T. S., & Johansen, P. Ø. (2013). Psychedelics and mental health: A population study. PloS one, 8(8), e63972. https://doi.org/10.1371/journal.pone.0063972
   PubMed Web of Science ®Google Scholar
• Langlois, S., Zern, A., Kelley, M. E., & Compton, M. T. (2020). Adversity in childhood/adolescence and premorbid tobacco, alcohol, and cannabis use among first-episode psychosis patients. Early Intervention in Psychiatry, 15(5), 1335–1342. https://doi.org/10.1111/eip.13086
   PubMed Web of Science ®Google Scholar
• Ligabue, K. P., Schuch, J. B., Scherer, J. N., Ornell, F., Roglio, V. S., Assuncao, V., Rebelatto, F. P., Hildalgo, M. P., Pechansky, F., Kessler, F., & von Diemen, L. (2020). Increased cortisol levels are associated with low treatment retention in crack cocaine users. Addictive Behaviors, 103, 106260. https://doi.org/10.1016/j.addbeh.2019.106260
   PubMed Web of Science ®Google Scholar
• Maremmani, A. G. I., Rovai, L., Rugani, F., Bacciardi, S., Dell’Osso, L., & Maremmani, I. (2014). Substance abuse and psychosis. The strange case of opioids. European Review for Medical and Pharmacological Sciences, 18(3), 287–302. https://pubmed.ncbi.nlm.nih.gov/24563427/
   PubMed Web of Science ®Google Scholar
• McGrath, J. J., Saha, S., Al-Hamzawi, A., Alonso, J., Bromet, E. J., Bruffaerts, R., Caldas-de-Almeida, J. M., Chiu, W. T., de Jonge, P., Fayyad, J., Florescu, S., Gureje, O., Haro, J. M., Hu, C., Kovess-Masfety, V., Lepine, J. P., Lim, C. C. W., Mora, M. E. M., Navarro-Mateu, F., … Kessler, R. C. (2015). Psychotic experiences in the general population: A cross-national analysis based on 31 261 respondents from 18 countries. JAMA Psychiatry, 72(7), 697–705. https://doi.org/10.1001/jamapsychiatry.2015.0575
   PubMed Web of Science ®Google Scholar
• McKenzie, R. R., Jr., Madadi, P., & Sharma, T. R. (2014). Alprazolam withdrawal delirium and brief reversible psychosis: A case report. The Primary Care Companion for CNS Disorders, 16(5), 26615 . https://doi.org/10.4088/PCC.14l01668
   PubMedGoogle Scholar
• Morton, W. A. (1999). Cocaine and psychiatric symptoms. The Primary Care Companion to the Journal of Clinical Psychiatry, 1(4), 109. https://doi.org/10.4088/PCC.v01n0403
   PubMedGoogle Scholar
• Nesvag, R., Reichborn-Kjennerud, T., Gillespie, N. A., Knudsen, G. P., Bramness, J. G., Kendler, K. S., & Ystrom, E. (2017). Genetic and environmental contributions to the association between cannabis use and psychotic-like experiences in young adult twins. Schizophrenia Bulletin, 43(3), 644–653. https://doi.org/10.1093/schbul/sbw101
   PubMed Web of Science ®Google Scholar
• Oh, H. Y., Koyanagi, A., Singh, F., & DeVylder, J. (2016). Is smoking tobacco associated with psychotic experiences across racial categories in the United States? Findings from the collaborative psychiatric epidemiological surveys. Psychiatry Research, 246, 58–61. https://doi.org/10.1016/j.psychres.2016.09.008
   PubMed Web of Science ®Google Scholar
• Oh, H., Smith, L., & Koyanagi, A. (2020). Health conditions and psychotic experiences: Cross-sectional findings from the American life panel. Frontiers in Psychiatry, 11, 612084. https://doi.org/10.3389/fpsyt.2020.612084
   Web of Science ®Google Scholar
• Oh, H., DeVylder, J. E., & Koyanagi, A. (2021). Psychotic experiences as a health indicator: A provisional framework. International Journal of Social Psychiatry 68(2), 244–252. https://doi.org/10.1177/0020764021992809
   PubMed Web of Science ®Google Scholar
• Piacentino, D., Kotzalidis, D., Del Casale, G., Rosaria Aromatario, A., Pomara, M., Girardi, C., & Sani, G. (2015). Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review. Current Neuropharmacology, 13(1), 101–121. https://doi.org/10.2174/1570159X13666141210222725
   PubMed Web of Science ®Google Scholar
• Potash, M. N., Gordon, K. A., & Conrad, K. L. (2009). Persistent psychosis and medical complications after a single ingestion of MDMA “Ecstasy”: A case report and review of the literature. Psychiatry (Edgmont), 6(7), 40. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2728937/
   PubMedGoogle Scholar
• Ramlakhan, J. U., Zomorrodi, R., Downar, J., Blumberger, D. M., Daskalakis, Z. J., George, T. P., Kiang, M., & Barr, M. S. (2018). Using mismatch negativity to investigate the pathophysiology of substance use disorders and comorbid psychosis. Clinical EEG and Neuroscience, 49(4), 226–237. https://doi.org/10.1177/1550059418760077
   PubMed Web of Science ®Google Scholar
• Ross, S., & Peselow, E. (2012). Co-occurring psychotic and addictive disorders: Neurobiology and diagnosis. Clinical Neuropharmacology, 35(5), 235–243. https://doi.org/10.1097/WNF.0b013e318261e193
   PubMed Web of Science ®Google Scholar
• Setien-Suero, E., Suarez-Pinilla, P., Ferro, A., Tabares-Seidedos, R., Crespo-Facorro, B., & Ayesa-Arriola, R. (2020). Childhood trauma and substance use underlying psychosis: A systematic review. European Journal of Psychotraumatology, 11(1), 1748342. https://doi.org/10.1080/20008198.2020.1748342
   PubMed Web of Science ®Google Scholar
• Shreeram, S. S., McDonald, T., & Dennison, S. (2001). Psychosis after ultrarapid opiate detoxification. American Journal of Psychiatry, 158(6), 970-970. https://doi.org/10.1176/appi.ajp.158.6.970
   PubMed Web of Science ®Google Scholar
• Swogger, M. T., & Walsh, Z. (2018). Kratom use and mental health: A systematic review. Drug and Alcohol Dependence, 183, 134–140. https://doi.org/10.1016/j.drugalcdep.2017.10.012
   PubMed Web of Science ®Google Scholar
• Thornton, L. K., Baker, A. L., Johnson, M. P., Kay-Lambkin, F., & Lewin, T. J. (2012). Reasons for substance use among people with psychotic disorders: Method triangulation approach. Psychology of Addictive Behaviors, 26(2), 279–288. https://doi.org/10.1037/a0026469
   PubMed Web of Science ®Google Scholar
• Wilson, L., Szigeti, A., Kearney, A., & Clarke, M. (2018). Clinical characteristics of primary psychotic disorders with concurrent substance abuse and substance-induced psychotic disorders. A systematic review. Schizophrenia Research, 197, 78–86. https://doi.org/10.1016/j.schres.2017.11.001
   PubMed Web of Science ®Google Scholar
• Wright, A. C., Cather, C., Farabaugh, A., Terechina, O., Pedrelli, P., Nyer, M., Fava, M., & Holt, D. J. (2020). Relationship between cannabis use and psychotic experiences in college students. Schizophrenia Research, 231, 198–204. https://doi.org/10.1016/j.schres.2021.04.004
   Web of Science ®Google Scholar